Rhodium(III)-Catalyzed C-H Activation: Ligand-Controlled Regioselective Synthesis of 4-Methyl-Substituted Dihydroisoquinolones

被引:29
作者
Barber, Joyann S. [1 ,2 ]
Scales, Stephanie [1 ]
Tran-Dube, Michelle [1 ]
Wang, Fen [1 ]
Sach, Neal W. [1 ]
Bernier, Louise [1 ]
Collins, Michael R. [1 ]
Zhu, JinJiang [1 ]
McAlpine, Indrawan J. [1 ]
Patman, Ryan L. [1 ]
机构
[1] Pfizer Oncol Med Chem, 10770 Sci Ctr Dr, San Diego, CA 92121 USA
[2] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
关键词
LIPOPHILIC EFFICIENCY; BOND FORMATION; DESIGN; DISCOVERY; CHEMISTRY;
D O I
10.1021/acs.orglett.9b02029
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Rh-catalyzed C-H functionalization of O-pivaloyl benzhydroxamic acids with propene gas provides access to 4-methyl-substituted dihydroisoquinolones. Good to excellent levels of regioselectivity are achieved using [(CpRhCl2)-Rh-t](2) as a precatalyst under optimized conditions. Thorough examination of aryl/heteroaryl O-pivaloyl hydroxamic acid substrates, ligand effects on C-H site selectivity, alkene scope, and demonstration of scale are discussed within.
引用
收藏
页码:5689 / 5693
页数:5
相关论文
共 43 条
  • [11] A simple guide for predicting regioselectivity in the coupling of polyhaloheteroaromatics
    Handy, ST
    Zhang, YN
    [J]. CHEMICAL COMMUNICATIONS, 2006, (03) : 299 - 301
  • [12] Hucldns J. R., 2013, J AM CHEM SOC, V135, P14492
  • [13] Ligand design for Rh(III)-catalyzed C-H activation: an unsymmetrical cyclopentadienyl group enables a regioselective synthesis of dihydroisoquinolones (vol 6, pg 254, 2015)
    Hyster, Todd K.
    Dalton, Derek M.
    Rovis, Tomislav
    [J]. CHEMICAL SCIENCE, 2018, 9 (41) : 8024 - 8024
  • [14] Ligand design for Rh(III)-catalyzed C-H activation: an unsymmetrical cyclopentadienyl group enables a regioselective synthesis of dihydroisoquinolones
    Hyster, Todd K.
    Dalton, Derek M.
    Rovis, Tomislav
    [J]. CHEMICAL SCIENCE, 2015, 6 (01) : 254 - 258
  • [15] Biotinylated Rh(III) Complexes in Engineered Streptavidin for Accelerated Asymmetric C-H Activation
    Hyster, Todd K.
    Knoerr, Livia
    Ward, Thomas R.
    Rovis, Tomislav
    [J]. SCIENCE, 2012, 338 (6106) : 500 - 503
  • [16] General Enantioselective C-H Activation with Efficiently Tunable Cyclopentadienyl Ligands
    Jia, Zhi-Jun
    Merten, Christian
    Gontla, Rajesh
    Daniliuc, Constantin G.
    Antonchick, Andrey P.
    Waldmann, Herbert
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (09) : 2429 - 2434
  • [17] Lipophilic Efficiency as an Important Metric in Drug Design
    Johnson, Ted W.
    Gallego, Rebecca A.
    Edwards, Martin P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (15) : 6401 - 6420
  • [18] Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
    Kung, Pei-Pei
    Rui, Eugene
    Bergqvist, Simon
    Bingham, Patrick
    Braganza, John
    Collins, Michael
    Cui, Mei
    Diehl, Wade
    Dac Dinh
    Fan, Connie
    Fantin, Valeria R.
    Gukasyan, Hovhannes J.
    Hu, Wenyue
    Huang, Buwen
    Kephart, Susan
    Krivacic, Cody
    Kumpf, Robert A.
    Li, Gary
    Maegley, Karen A.
    McAlpine, Indrawan
    Nguyen, Lisa
    Ninkovic, Sacha
    Ornelas, Martha
    Ryskin, Michael
    Scales, Stephanie
    Sutton, Scott
    Tatlock, John
    Verhelle, Dominique
    Wang, Fen
    Wells, Peter
    Wythes, Martin
    Yamazaki, Shinji
    Yip, Brian
    Yu, Xiu
    Zehnder, Luke
    Zhang, Wei-Guo
    Rollins, Robert A.
    Edwards, Martin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8306 - 8325
  • [19] The influence of drug-like concepts on decision-making in medicinal chemistry
    Leeson, Paul D.
    Springthorpe, Brian
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) : 881 - 890
  • [20] Gliquidone contributes to improvement of type 2 diabetes mellitus management: A review of pharmacokinetic and clinical trial data
    Malaisse W.J.
    [J]. Drugs in R & D, 2006, 7 (6) : 331 - 337